Cancer Cell, volume 35, issue 6, pages 932-947.e8

Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes

Xue Ruidong 1
Lu Chen
Zhang Chong 1
Fujita Masashi 2
Li Ruo-Yan 1
Yan Shu-mei 3
Ong Chin-Ann Johnny 4
Liao Xiwen 5
Gao Qiang 6, 7
Sasagawa Shota 2
Li Yang 1
Wang Jincheng 1
Guo Hua 8
Huang Qi-tao 3
Zhong Qian 3
Tan Jing 3
QI LISHA 9
Gong Wenchen 9
Hong Zhixian 10
Li Meng 11
Zhao Jingmin 12
Peng Tao 5
Lu Yinying 13
Lim Kiat Hon Tony 14
Boot Arnoud 15
Ono Atushi 16
Chayama Kazuaki 16
Zhang Zemin 1
Rozen Steven G 15
Teh Bin S. 17
Wang Xin-Wei 18
Nakagawa Hidewaki 2
Zeng Musheng 3
Bai Fan 1
Wang Jiadong 19, 20
2
 
Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan
4
 
Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore 169610, Singapore
5
 
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
6
 
Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai 200032, China
10
 
Department of Hepatobiliary Surgery, Beijing 302 Hospital, Beijing 100039, China
11
 
Department of Ultrasonography, Beijing 302 Hospital, Beijing 100039, China
12
 
Department of Pathology and Hepatology, Beijing 302 Hospital, Beijing 100039, China
13
 
Comprehensive Liver Cancer Center, Beijing 302 Hospital, Beijing 100039, China
14
 
Department of Anatomical Pathology, Singapore General Hospital, Singapore 169608, Singapore
15
 
Centre for Computational Biology, Duke-NUS Medical School, Singapore 169857, Singapore.
16
 
Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan
17
 
Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore 169610, Singapore
18
 
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
Publication typeJournal Article
Publication date2019-06-01
Journal: Cancer Cell
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor50.3
ISSN15356108, 18783686
Cancer Research
Oncology
Abstract
We performed genomic and transcriptomic sequencing of 133 combined hepatocellular and intrahepatic cholangiocarcinoma (cHCC-ICC) cases, including separate, combined, and mixed subtypes. Integrative comparison of cHCC-ICC with hepatocellular carcinoma and intrahepatic cholangiocarcinoma revealed that combined and mixed type cHCC-ICCs are distinct subtypes with different clinical and molecular features. Integrating laser microdissection, cancer cell fraction analysis, and single nucleus sequencing, we revealed both mono- and multiclonal origins in the separate type cHCC-ICCs, whereas combined and mixed type cHCC-ICCs were all monoclonal origin. Notably, cHCC-ICCs showed significantly higher expression of Nestin, suggesting Nestin may serve as a biomarker for diagnosing cHCC-ICC. Our results provide important biological and clinical insights into cHCC-ICC.

Citations by journals

1
2
3
4
5
6
7
8
9
Cancers
Cancers, 9, 5.39%
Cancers
9 publications, 5.39%
Journal of Hepatology
Journal of Hepatology, 8, 4.79%
Journal of Hepatology
8 publications, 4.79%
Nature Communications
Nature Communications, 6, 3.59%
Nature Communications
6 publications, 3.59%
Hepatology
Hepatology, 5, 2.99%
Hepatology
5 publications, 2.99%
Frontiers in Oncology
Frontiers in Oncology, 5, 2.99%
Frontiers in Oncology
5 publications, 2.99%
Nature Reviews Gastroenterology and Hepatology
Nature Reviews Gastroenterology and Hepatology, 4, 2.4%
Nature Reviews Gastroenterology and Hepatology
4 publications, 2.4%
Histopathology
Histopathology, 4, 2.4%
Histopathology
4 publications, 2.4%
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 3, 1.8%
Journal of Cancer Research and Clinical Oncology
3 publications, 1.8%
Frontiers in Immunology
Frontiers in Immunology, 3, 1.8%
Frontiers in Immunology
3 publications, 1.8%
BMC Cancer
BMC Cancer, 3, 1.8%
BMC Cancer
3 publications, 1.8%
Scientific Reports
Scientific Reports, 3, 1.8%
Scientific Reports
3 publications, 1.8%
Gut
Gut, 3, 1.8%
Gut
3 publications, 1.8%
International Journal of Surgical Pathology
International Journal of Surgical Pathology, 2, 1.2%
International Journal of Surgical Pathology
2 publications, 1.2%
Journal of Translational Medicine
Journal of Translational Medicine, 2, 1.2%
Journal of Translational Medicine
2 publications, 1.2%
Oncogene
Oncogene, 2, 1.2%
Oncogene
2 publications, 1.2%
Communications Biology
Communications Biology, 2, 1.2%
Communications Biology
2 publications, 1.2%
Nature
Nature, 2, 1.2%
Nature
2 publications, 1.2%
Cancer Cell
Cancer Cell, 2, 1.2%
Cancer Cell
2 publications, 1.2%
Heliyon
Heliyon, 2, 1.2%
Heliyon
2 publications, 1.2%
Liver International
Liver International, 2, 1.2%
Liver International
2 publications, 1.2%
Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma, 2, 1.2%
Journal of Hepatocellular Carcinoma
2 publications, 1.2%
Briefings in Bioinformatics
Briefings in Bioinformatics, 2, 1.2%
Briefings in Bioinformatics
2 publications, 1.2%
Science advances
Science advances, 2, 1.2%
Science advances
2 publications, 1.2%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 1.2%
International Journal of Molecular Sciences
2 publications, 1.2%
Translational Cancer Research
Translational Cancer Research, 2, 1.2%
Translational Cancer Research
2 publications, 1.2%
Zeitschrift fur Gastroenterologie
Zeitschrift fur Gastroenterologie, 2, 1.2%
Zeitschrift fur Gastroenterologie
2 publications, 1.2%
Frontiers in Genetics
Frontiers in Genetics, 1, 0.6%
Frontiers in Genetics
1 publication, 0.6%
Current Bioinformatics
Current Bioinformatics, 1, 0.6%
Current Bioinformatics
1 publication, 0.6%
Aging
Aging, 1, 0.6%
Aging
1 publication, 0.6%
1
2
3
4
5
6
7
8
9

Citations by publishers

5
10
15
20
25
30
35
40
45
50
Springer Nature
Springer Nature, 49, 29.34%
Springer Nature
49 publications, 29.34%
Elsevier
Elsevier, 27, 16.17%
Elsevier
27 publications, 16.17%
Wiley
Wiley, 18, 10.78%
Wiley
18 publications, 10.78%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 14, 8.38%
Multidisciplinary Digital Publishing Institute (MDPI)
14 publications, 8.38%
Frontiers Media S.A.
Frontiers Media S.A., 10, 5.99%
Frontiers Media S.A.
10 publications, 5.99%
Wolters Kluwer Health
Wolters Kluwer Health, 4, 2.4%
Wolters Kluwer Health
4 publications, 2.4%
SAGE
SAGE, 4, 2.4%
SAGE
4 publications, 2.4%
Oxford University Press
Oxford University Press, 4, 2.4%
Oxford University Press
4 publications, 2.4%
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR), 4, 2.4%
American Association for Cancer Research (AACR)
4 publications, 2.4%
Dove Medical Press
Dove Medical Press, 3, 1.8%
Dove Medical Press
3 publications, 1.8%
BMJ
BMJ, 3, 1.8%
BMJ
3 publications, 1.8%
AME Publishing Company
AME Publishing Company, 3, 1.8%
AME Publishing Company
3 publications, 1.8%
Taylor & Francis
Taylor & Francis, 2, 1.2%
Taylor & Francis
2 publications, 1.2%
American Association for the Advancement of Science (AAAS)
American Association for the Advancement of Science (AAAS), 2, 1.2%
American Association for the Advancement of Science (AAAS)
2 publications, 1.2%
Thieme
Thieme, 2, 1.2%
Thieme
2 publications, 1.2%
Bentham Science
Bentham Science, 1, 0.6%
Bentham Science
1 publication, 0.6%
Impact Journals
Impact Journals, 1, 0.6%
Impact Journals
1 publication, 0.6%
Spandidos Publications
Spandidos Publications, 1, 0.6%
Spandidos Publications
1 publication, 0.6%
Baishideng Publishing Group
Baishideng Publishing Group, 1, 0.6%
Baishideng Publishing Group
1 publication, 0.6%
American Society for Biochemistry and Molecular Biology
American Society for Biochemistry and Molecular Biology, 1, 0.6%
American Society for Biochemistry and Molecular Biology
1 publication, 0.6%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 0.6%
Public Library of Science (PLoS)
1 publication, 0.6%
KeAi Communications Co.
KeAi Communications Co., 1, 0.6%
KeAi Communications Co.
1 publication, 0.6%
Pacini Editore SpA, 1, 0.6%
Pacini Editore SpA
1 publication, 0.6%
American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO), 1, 0.6%
American Society of Clinical Oncology (ASCO)
1 publication, 0.6%
Annual Reviews
Annual Reviews, 1, 0.6%
Annual Reviews
1 publication, 0.6%
Hans Publishers
Hans Publishers, 1, 0.6%
Hans Publishers
1 publication, 0.6%
Cairo University
Cairo University, 1, 0.6%
Cairo University
1 publication, 0.6%
5
10
15
20
25
30
35
40
45
50
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Xue R. et al. Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes // Cancer Cell. 2019. Vol. 35. No. 6. p. 932-947.e8.
GOST all authors (up to 50) Copy
Xue R., Lu C., Zhang C., Fujita M., Li R., Yan S., Ong C. J., Liao X., Gao Q., Sasagawa S., Li Y., Wang J., Guo H., Huang Q., Zhong Q., Tan J., QI L., Gong W., Hong Z., Li M., Zhao J., Peng T., Lu Y., Lim K. H. T., Boot A., Ono A., Chayama K., Zhang Z., Rozen S., Teh B. S., Wang X., Nakagawa H., Zeng M., Bai F., Wang J. Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes // Cancer Cell. 2019. Vol. 35. No. 6. p. 932-947.e8.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.ccell.2019.04.007
UR - https://doi.org/10.1016%2Fj.ccell.2019.04.007
TI - Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
T2 - Cancer Cell
AU - Xue, Ruidong
AU - Lu, Chen
AU - Zhang, Chong
AU - Fujita, Masashi
AU - Li, Ruo-Yan
AU - Yan, Shu-mei
AU - Ong, Chin-Ann Johnny
AU - Liao, Xiwen
AU - Gao, Qiang
AU - Sasagawa, Shota
AU - Li, Yang
AU - Wang, Jincheng
AU - Guo, Hua
AU - Huang, Qi-tao
AU - Zhong, Qian
AU - Tan, Jing
AU - QI, LISHA
AU - Gong, Wenchen
AU - Hong, Zhixian
AU - Li, Meng
AU - Zhao, Jingmin
AU - Peng, Tao
AU - Lu, Yinying
AU - Lim, Kiat Hon Tony
AU - Boot, Arnoud
AU - Ono, Atushi
AU - Chayama, Kazuaki
AU - Zhang, Zemin
AU - Rozen, Steven G
AU - Teh, Bin S.
AU - Wang, Xin-Wei
AU - Nakagawa, Hidewaki
AU - Zeng, Musheng
AU - Bai, Fan
AU - Wang, Jiadong
PY - 2019
DA - 2019/06/01 00:00:00
PB - Elsevier
SP - 932-947.e8
IS - 6
VL - 35
PMID - 31130341
SN - 1535-6108
SN - 1878-3686
ER -
BibTex |
Cite this
BibTex Copy
@article{2019_Xue,
author = {Ruidong Xue and Chen Lu and Chong Zhang and Masashi Fujita and Ruo-Yan Li and Shu-mei Yan and Chin-Ann Johnny Ong and Xiwen Liao and Qiang Gao and Shota Sasagawa and Yang Li and Jincheng Wang and Hua Guo and Qi-tao Huang and Qian Zhong and Jing Tan and LISHA QI and Wenchen Gong and Zhixian Hong and Meng Li and Jingmin Zhao and Tao Peng and Yinying Lu and Kiat Hon Tony Lim and Arnoud Boot and Atushi Ono and Kazuaki Chayama and Zemin Zhang and Steven G Rozen and Bin S. Teh and Xin-Wei Wang and Hidewaki Nakagawa and Musheng Zeng and Fan Bai and Jiadong Wang},
title = {Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes},
journal = {Cancer Cell},
year = {2019},
volume = {35},
publisher = {Elsevier},
month = {jun},
url = {https://doi.org/10.1016%2Fj.ccell.2019.04.007},
number = {6},
pages = {932--947.e8},
doi = {10.1016/j.ccell.2019.04.007}
}
MLA
Cite this
MLA Copy
Xue, Ruidong, et al. “Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.” Cancer Cell, vol. 35, no. 6, Jun. 2019, pp. 932-947.e8. https://doi.org/10.1016%2Fj.ccell.2019.04.007.
Found error?